NCT01616069View on ClinicalTrials.gov

Assessment of Hemodynamic Response in Cardiopulmonary Bypass Graft After Cardiopulmonary Bypass Using Transesophegeal Echocardiography

PHASE4CompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

February 29, 2012

Study Completion Date

December 31, 2013

Conditions
Cardiopulmonary Bypass Graft
Interventions
DRUG

epinephrine and levosimendan

epinephrine (0,06mcg/kg/min), levosimendan (0,2 mcg/kg/min)

Trial Locations (1)

3600-100

National Institute of Cardiology / Ministry of Health, Rio de Janeiro

All Listed Sponsors
collaborator

Universidade Federal do Rio de Janeiro

OTHER

collaborator

National Institute of Cardiology/Ministry of Health

UNKNOWN

lead

Federal University of Juiz de Fora

OTHER

NCT01616069 - Assessment of Hemodynamic Response in Cardiopulmonary Bypass Graft After Cardiopulmonary Bypass Using Transesophegeal Echocardiography | Biotech Hunter | Biotech Hunter